Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study.
Vogt, B
Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study. [electronic resource] - Transplantation proceedings Jun 2006 - 1301-6 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0041-1345
10.1016/j.transproceed.2006.02.125 doi
Adult
Aged
Creatinine--metabolism
Female
Follow-Up Studies
Humans
Immunosuppressive Agents--administration & dosage
Kidney Function Tests
Kidney Transplantation--immunology
Male
Middle Aged
Mycophenolic Acid--administration & dosage
Safety
Tablets, Enteric-Coated
Time Factors
Treatment Failure
Treatment Outcome
Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study. [electronic resource] - Transplantation proceedings Jun 2006 - 1301-6 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0041-1345
10.1016/j.transproceed.2006.02.125 doi
Adult
Aged
Creatinine--metabolism
Female
Follow-Up Studies
Humans
Immunosuppressive Agents--administration & dosage
Kidney Function Tests
Kidney Transplantation--immunology
Male
Middle Aged
Mycophenolic Acid--administration & dosage
Safety
Tablets, Enteric-Coated
Time Factors
Treatment Failure
Treatment Outcome